Page last updated: 2024-10-20

tryptamine and Depressive Disorder, Major

tryptamine has been researched along with Depressive Disorder, Major in 4 studies

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Fricke, J1
Kargbo, R1
Regestein, L1
Lenz, C1
Peschel, G1
Rosenbaum, MA1
Sherwood, A1
Hoffmeister, D1
Holt, A1
Gaszner, P2
Miklya, I2

Reviews

3 reviews available for tryptamine and Depressive Disorder, Major

ArticleYear
Imidazoline binding sites on receptors and enzymes: emerging targets for novel antidepressant drugs?
    Journal of psychiatry & neuroscience : JPN, 2003, Volume: 28, Issue:6

    Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Binding Sites; Brain; Clonidine; Depressive Disord

2003
The use of the synthetic enhancer substances (-)-deprenyl and (-)-BPAP in major depression.
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2004, Volume: 6, Issue:4

    Topics: Benzofurans; Catecholamines; Depressive Disorder, Major; Humans; Mesencephalon; Neuroprotective Agen

2004
Major depression and the synthetic enhancer substances, (-)-deprenyl and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.
    Progress in neuro-psychopharmacology & biological psychiatry, 2006, Volume: 30, Issue:1

    Topics: Animals; Benzofurans; Depressive Disorder, Major; Humans; Monoamine Oxidase Inhibitors; Neuroprotect

2006

Other Studies

1 other study available for tryptamine and Depressive Disorder, Major

ArticleYear
Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2020, Jul-02, Volume: 26, Issue:37

    Topics: Agaricales; Biocatalysis; Depressive Disorder, Major; Humans; Psilocybe; Psilocybin; Tryptamines

2020